ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING TASOCITINIB

ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING TASOCITINIB

The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SIEVERT, FRANK, STEFAN, RALPH
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms.